LFVN Lifevantage Corporation

LifeVantage Corporation engages in the identification, research, development, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. The company offers Protandim, a line of scientifically-validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, and hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. The company sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and China. LifeVantage Corporation is headquartered in Sandy, Utah.

Date	Price Target	Rating	Analyst
1/14/2025	$35.00	Buy	Craig Hallum
12/19/2024	$26.00	Buy	Lake Street

Lifevantage Corporation

Recent Analyst Ratings for Lifevantage Corporation

Lifevantage Corporation Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Craig Hallum initiated coverage on Lifevantage with a new price target

Lake Street initiated coverage on Lifevantage with a new price target

Lifevantage Corporation Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Lewis Darwin bought $4,873 worth of shares (379 units at $12.86), increasing direct ownership by 0.33% to 116,767 units (SEC Form 4)

Director Mauro Garry Paul bought $26,338 worth of shares (2,150 units at $12.25), increasing direct ownership by 0.70% to 86,087 units (SEC Form 4)

Director Lewis Darwin bought $3,632 worth of shares (227 units at $16.00), increasing direct ownership by 0.20% to 116,388 units (SEC Form 4)

Director Lewis Darwin bought $3,618 worth of shares (351 units at $10.31), increasing direct ownership by 0.33% to 108,342 units (SEC Form 4)

Director Mauro Garry Paul bought $11,848 worth of shares (1,600 units at $7.41), increasing direct ownership by 0.78% to 77,667 units (SEC Form 4)

Director Lewis Darwin bought $3,610 worth of shares (489 units at $7.38), increasing direct ownership by 0.45% to 107,991 units (SEC Form 4)

Lewis Darwin bought $3,142 worth of shares (449 units at $7.00), increasing direct ownership by 0.42% to 107,502 units (SEC Form 4)

Mauro Garry Paul gifted 30,893 shares, bought $1,128 worth of shares (199 units at $5.67) and received a gift of 30,893 shares, decreasing direct ownership by 29% to 77,067 units (SEC Form 4)

Lewis Darwin bought $3,118 worth of shares (460 units at $6.78), increasing direct ownership by 0.43% to 107,053 units (SEC Form 4)

Mauro Garry Paul bought $89,166 worth of shares (18,824 units at $4.74), increasing direct ownership by 11% to 71,183 units (SEC Form 4)